UBS Maintains Buy on Boston Scientific, Raises Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Danielle Antalffy maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $63 to $66.
September 21, 2023 | 4:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst maintains a Buy rating on Boston Scientific and raises the price target from $63 to $66.
The news of UBS maintaining a Buy rating and raising the price target for Boston Scientific is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100